A. Kajikawa et al., MUCOSA-PREFERENTIAL DNA ADDUCT FORMATION BY 2-AMINO-3-METHYLIMIDAZO[4,5-F]QUINOLINE IN THE RAT COLONIC WALL, Cancer research, 55(13), 1995, pp. 2769-2773
The mechanism of mucosa-specific formation of DNA adducts, which was f
ound recently in human intestines, was studied in male F344 rats treat
ed with 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). There are three
conceivable pathways for p.o. administered IQ to reach the target colo
nic mucosal cells: pathway 1, through the digestive canal which expose
s from the lumenal direction; pathway 2, following enterohepatic circu
lation re-expose from the lumenal direction; and pathway 3, exposure v
ia blood circulation. To investigate these possible pathways, the foll
owing surgical procedures were performed: (a) portal catheterization f
or IQ administration to eliminate pathway 1 and (b) choledochal cathet
erization for bile drainage to eliminate pathway 2. When both procedur
es are combined, only pathway 3 Is active. Four types of IQ-DNA adduct
s were commonly observed in the colons of all experimental groups, wit
h no qualitative difference between the mucosal and muscular layers. W
hen IQ-HCl was administered by p.o. gavage at a dose of 100 mu mol/kg
body weight, approximately 70% of the IQ-DNA adducts in the colonic mu
cosa (13.1 +/- 4.3 adducts/10(7) nucleotides) was induced through path
way 1. Pathway 3 induced the remaining 30% of mucosal adducts, produci
ng equal adduct levels in both layers. Pathway 2 did not work for addu
ct formation. The DNA adduct formation was unaffected in the presence
of intestinal flora, indicating that detoxified IQ does not reactivate
by floral enzymes. In conclusion, mucosa-specific DNA adduct formatio
n in the colon is caused most likely by the absorption of carcinogens
through the lumen.